Search results

  1. The committee noted that there was no clinical evidence showing that having patiromer improved length or quality of life or allowed patients to stay on optimal doses of renin-angiotensin-aldosterone system (RAAS) inhibitors. It therefore considered that it would be valuable to have studies comparing patiromer plus standard care with standard care alone in people with confirmed hyperkalaemia of 6.0 mmol/litre and above, and that these should investigate: - mortality- disease progression- patterns of RAAS inhibitor use- healthcare utilisation and- health-related quality of life. The committee recalled that the DIAMOND trial is ongoing and may help to provide evidence on mortality (see section 3.11). However, the trial is not going to complete until 2022. The committee concluded that the guidance should be reviewed when evidence from DIAMOND is available.

    Recommendation ID TA623/1 Question The committee noted that there was no clinical evidence showing that having patiromer improved length

  2. Episcissors-60 show promise for mediolateral episiotomy. But there is currently not enough evidence to support the case for routine adoption in the NHS. Research is recommended to address uncertainties about the efficacy and safety of using Episcissors-60. This research should: - determine if using Episcissors-60 in addition to other care bundle measures is more effective in achieving an optimal episiotomy angle and in preventing episiotomy-related obstetric anal sphincter injuries (OASI) than standard episiotomy scissors - include patient-reported outcome measures - address potential equality considerations by ensuring patients at greatest risk of OASI are recruited - determine the relative cost of using Episcissors-60 compared with standard episiotomy scissors.

    Recommendation ID MTG47/1 Question Episcissors-60 show promise for mediolateral episiotomy. But there is currently not enough evidence

  3. The percentage of patients with diabetes who have had the following care processes performed in the preceding 12 months: BMI measurement; BP measurement; HbA1c measurement; Cholesterol measurement; Record of smoking status; Foot examination; Albumin: creatinine ratio; Serum creatinine measurement

    The percentage of patients with diabetes who have had the following care processes performed in the preceding 12 months: BMI measurement; BP...

  4. Hearing loss

    Everything NICE has said on hearing loss or impairment in adults in an interactive flowchart

  5. Tinnitus

    Everything NICE has said on tinnitus in an interactive flowchart.

  6. Drug misuse management in over 16s

    Everything NICE has said on psychosocial interventions and opioid detoxification for drug misuse in an interactive flowchart

  7. Self-harm

    Everything NICE has said on assessing and managing self-harm in an interactive flowchart

  8. Social anxiety disorder

    Everything NICE has said on recognising, assessing and treating social anxiety disorder in children, young people and adults in an interactive flowchart

  9. Varicose veins in the legs

    Everything NICE has said on diagnosing and managing varicose veins in the legs in an interactive flowchart.

  10. Supporting adult carers

    Everything NICE has said on supporting adults carers in an interactive flowchart

  11. Urogenital conditions

    Everything NICE has said on urogenital conditions in an interactive flowchart

  12. Impetigo

    Everything NICE has said on the use of antiseptics and antibiotics to manage impetigo in an interactive flowchart

  13. The percentage of women with epilepsy aged 18 or over and who have not attained the age of 45 who are taking antiepileptic drugs who have a record of being given information and advice about pregnancy or conception or contraception tailored to their pregnancy and contraceptive intentions recorded in the preceding 12 months

    The percentage of women with epilepsy aged 18 or over and who have not attained the age of 45 who are taking antiepileptic drugs who have a record of...